GREEN CROSS WellBeing Corporation
GREEN CROSS WellBeing Corporation provides personalized nutrition injections in South Korea. The company offers health supplements and food; prescription drugs; and aesthetics, as well as nutritional injections, including vitamins and antioxidants. GREEN CROSS WellBeing Corporation was founded in 2004 and is headquartered in Seoul, South Korea.
Market Cap & Net Worth: GREEN CROSS WellBeing Corporation (234690)
GREEN CROSS WellBeing Corporation (KQ:234690) has a market capitalization of $110.29 Million (₩161.48 Billion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #21058 globally and #965 in its home market, demonstrating a 1.68% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GREEN CROSS WellBeing Corporation's stock price ₩9100.00 by its total outstanding shares 17745166 (17.75 Million).
GREEN CROSS WellBeing Corporation Market Cap History: 2019 to 2026
GREEN CROSS WellBeing Corporation's market capitalization history from 2019 to 2026. Data shows change from $123.13 Million to $110.29 Million (-4.15% CAGR).
Index Memberships
GREEN CROSS WellBeing Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.03% | #439 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.03% | #439 of 1384 |
Weight: GREEN CROSS WellBeing Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
GREEN CROSS WellBeing Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GREEN CROSS WellBeing Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
GREEN CROSS WellBeing Corporation's market cap is 0.00 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.02x
GREEN CROSS WellBeing Corporation's market cap is 0.02 times its annual earnings
0.11x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $123.13 Million | $66.94 Billion | $5.70 Billion | 0.00x | 0.02x |
| 2020 | $164.02 Million | $75.60 Billion | $1.53 Billion | 0.00x | 0.11x |
| 2021 | $119.86 Million | $90.97 Billion | $6.70 Billion | 0.00x | 0.02x |
| 2022 | $98.34 Million | $109.73 Billion | $8.00 Billion | 0.00x | 0.01x |
| 2023 | $98.53 Million | $120.53 Billion | $6.75 Billion | 0.00x | 0.01x |
| 2024 | $121.92 Million | $133.80 Billion | $7.07 Billion | 0.00x | 0.02x |
Competitor Companies of 234690 by Market Capitalization
Companies near GREEN CROSS WellBeing Corporation in the global market cap rankings as of March 18, 2026.
Key companies related to GREEN CROSS WellBeing Corporation by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
GREEN CROSS WellBeing Corporation Historical Marketcap From 2019 to 2026
Between 2019 and today, GREEN CROSS WellBeing Corporation's market cap moved from $123.13 Million to $ 110.29 Million, with a yearly change of -4.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩110.29 Million | -0.44% |
| 2025 | ₩110.77 Million | -9.15% |
| 2024 | ₩121.92 Million | +23.74% |
| 2023 | ₩98.53 Million | +0.20% |
| 2022 | ₩98.34 Million | -17.96% |
| 2021 | ₩119.86 Million | -26.92% |
| 2020 | ₩164.02 Million | +33.21% |
| 2019 | ₩123.13 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of GREEN CROSS WellBeing Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $110.29 Million USD |
| MoneyControl | $110.29 Million USD |
| MarketWatch | $110.29 Million USD |
| marketcap.company | $110.29 Million USD |
| Reuters | $110.29 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.